低毒性環境での調整可能な肺発現mRNA配送プラットフォーム
Palas Balakdas Tiwade1, Yutian Ma1, Rachel VanKeulen-Miller2
1Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Journal of the American Chemical Society
|June 14, 2024
まとめ
調整可能なナノ粒子プラットフォーム (TULEP) を開発し,メッセンジャーRNA (mRNA) 伝達のために,肺疾患の低酸素 (低酸素) 状態での有効性を最適化しました. これは現在のmRNA治療の重要な限界を解決します.
科学分野:
- バイオテクノロジー
- ナノ医療
- 分子生物学
背景:
- メッセンジャーRNA (mRNA) 配送プラットフォームは,正常な酸素レベルに最適化されており,肺のような臓器に影響を与える疾患での使用を制限しています.
- 多くの疾患に共通する低酸素状態は,mRNA治療の有効性を80%以上低下させます.
研究 の 目的:
- 効率的なmRNA配送のための調節可能なナノ粒子プラットフォーム (TULEP) を開発し,特に低酸素環境のために最適化.
- mRNAの伝達メカニズムを調査し,低酸素による有効性の欠陥を克服する.
主な方法:
- TULEPナノ粒子をmRNAペイロードで作成するための新しいアミノアクリラートポリマーを合成し,特徴づけました.
- 肺細胞におけるTULEPの細胞関連性,内分細胞分裂,内分細胞脱出,およびタンパク質発現をノーマキシックおよび低酸素条件で評価した.
- アデノシントリフォスファート (ATP) を使って低酸素症に対するTULEPの有効性を調整し,マウスでの*in vivo*パフォーマンスを評価した.
主要な成果:
- TULEPナノ粒子への mRNA複合化が成功していることが実証されました.
- TULEPの伝達メカニズムと肺細胞のタンパク質発現を特徴づけた.
- ATPを用いた低毒性条件下でのTULEP有効性の調整可能な強化が示され,マウスにおける良好な*in vivo*生物分布と耐受性が示された.
結論:
- 調節可能な肺発現ナノ粒子プラットフォーム (TULEP) は,特に低酸素環境では,効果的なmRNA配送を提供します.
- より広範な治療用途のためのmRNA配送システムの設計において酸素レベルを考慮する重要性を強調する.
関連する概念動画
02:31Nuclear Export of mRNA
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
02:27Nonsense-mediated mRNA Decay
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
02:22Regulated mRNA Transport
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...
02:31Nuclear Export of mRNA
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
02:27Nonsense-mediated mRNA Decay
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
02:22Regulated mRNA Transport
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...